News Coverage of UAlbany, NYSDOH Observational Study on Hydroxychloroquine

A statue of Minerva stands in the Science Library atrium. Glass windows are behind her.

ALBANY, N.Y. (May 26, 2020) - Results from an observational study of hydroxychloroquine and azithromycin were released from the University at Albany and the New York State Department of Health (NYSDOH) in early May; the findings were published in the Journal of the American Medical Association (JAMA).

Today, the paper performs in the top 5% of all research outputs scored by Altmetric, which measures research impact, and is one of the highest-scoring outputs from JAMA (#8 of 27,454). In addition, the study has received news coverage from 136+ outlets and 6,150+ tweets.

Some highlights of news coverage include:

U.S. News & World Report: Health Highlights: May 12, 2020
Politico: Hydroxychloroquine shows no benefit against coronavirus in N.Y. study
CNBC: Another study shows drug touted by Trump doesn’t help coronavirus patients, but it can raise heart attack risk
Express: Coronavirus Breakthrough: Over 50s drug trial starts recruiting on this date
International Business Times: Coronavirus Treatment: Trump’s Hydroxychloroquine Increases Heart Attack Risks Among COVID-19 Patients
CNN: Yet another study shows how hydroxychloroquine doesn’t work against Covid-19
Salon: Unproven drug treatment for coronavirus championed by Trump and Fox News shows no benefit: study
Daily Mail: Yet ANOTHER study finds that the malaria drug hydroxychloroquine – touted by Trump as a ‘game changer’ for treating coronavirus – did NOT help patients and some faced higher risks of heart attacks

Visit the School of Public Health’s website to learn more about faculty, staff and student involvement in COVID-19 response and visit UAlbany’s COVID-19 website to learn more about the University’s response and other relevant information.